Objective: Fully differential topologies are well-suited for biopotential amplifiers, mainly for single-supply battery-powered circuits such as portable wearable devices where a reduced number of parts is desired. A novel fully differential biopotential amplifier is proposed with the goal of providing electrode offset rejection, bandwidth limitation, and a temporal response compliant with biomedical standards with only a single commercial quad operational amplifier (OA) integrated circuit.